Results 21 to 30 of about 2,746 (190)

Estradiol valerate and dienogest: a new approach to oral contraception

International Journal of Women's Health, 2011
Jessica W Kiley, Lee P ShulmanSection of Family Planning and Contraception, Department of Obstetrics and Gynecology, Feinberg School of Medicine of Northwestern University, Chicago, IL, USAAbstract: Most combination oral contraceptives contain ethinyl ...
Kiley JW, Shulman LP
doaj   +2 more sources

Effectiveness of the cyclic administration of dienogest in a case of pathological disappearance of intestinal endometriosis

International Journal of Women's Health, 2013
Ryo Tamura, Ikunosuke Tsuneki, Toru Yanase Department of Obstetrics and Gynecology, Niigata City General Hospital, Niigata, Japan Abstract: We have reported good control of atypical genital bleeding when using a cyclic administration of dienogest ...
Tamura R, Tsuneki I, Yanase T
doaj   +1 more source

Efficacy and safety of long-term administration of dienogest for deep infiltrative endometriosis [PDF]

РМЖ. Мать и дитя, 2019
V.G. Volkov1, N.E. Malykh2 1Tula State University, Tula, Russian Federation 2Tula Multidisciplinary Medical Center «Consultant Farm», Tula, Russian Federation Deep infiltrative endometriosis is a type of endometriosis characterized by 5-mm ...
Volkov V.G., N.E. Malykh
doaj   +1 more source

Efficacy and Safety of Elagolix Versus Dienogest for Treatment of Moderate-to-Severe Endometriosis Pain: A Phase III, Multicentric, Double-Blind, Active-Controlled, Non-Inferiority Study. [PDF]

BJOG
ABSTRACT Objective To compare the efficacy, safety and tolerability of elagolix with dienogest in women with moderate‐to‐severe endometriosis‐associated pain. Design A multicentre, double‐blind, double‐dummy, randomised, parallel‐group, active‐controlled, non‐inferiority phase III study. Setting Nineteen clinical centres across India.
Bhoir S, Patel J, Palve T, Dash MK, Saigal S, Kamilya G, Srivastava S, Savalia K, Gupta T, Choudhary D, Rangaswamy M, Bhatt VV, Gupta N, Ponnuru M, Shah P, Shetty A, Saha S, Quadros R, Pandit S, Patil D, Patel P, Ghadge P, Lakhwani L, Mehta S, Joglekar S.   +24 more
europepmc   +2 more sources

Three-dimensional patient-derived endometriosis model for drug evaluation. [PDF]

Acta Obstet Gynecol Scand
In this study, we developed a coculturing model with stromal cells and epithelial organoids to mimic the endometriotic lesion and for further evaluation of drug effects. Abstract Introduction Endometriomsis (EMs) is a complex and chronic gynecological disease characterized by distressing symptoms.
Li Y, Shao W, Gao X, Wang Y, Li J, Zhang L, Xing Y, Su W, Cheng Y, Wang L, Liu S.   +10 more
europepmc   +2 more sources

Visual Evoked Potential Findings in Endometriosis Patients Treated with Dienogest [PDF]

, 2023
Purpose: The aim of the present study was to investigate possible toxic effects of Dienogest treatment on visual pathway among endometriosis patients using visual evoked potential (VEP) measurements.
Eslami Vaghar , Mohammad, Shushtarian, Seyed Mohammad Masoud   +1 more
core   +1 more source

Comparison of the Efficacy and Tolerability of Dienogest and Dienogest Plus Ethinylestradiol on Endometriosis Related-Pain

Gynecology Obstetrics & Reproductive Medicine, 2020
Objective: Endometriosis is a common gynecological condition that affects many women of reproductive age worldwide and is a major cause of pain and infertility.
Tolga Karacan, Huseyin Kiyak, Eser Ozyurek, Mevlide San, Engin Oral   +4 more
doaj   +1 more source

Treatment of endometriosis with dienogest in combination with traditional Chinese medicine: A systematic review and meta-analysis

Frontiers in Surgery, 2022
BackgroundEndometriosis is now considered to be a systemic disease rather than a disease that primarily affects the pelvis. Dienogest (DNG) has unique advantages in the treatment of endometriosis, but it also has side effects.
Yu’e Wu, Yujie Liu, Huanhuan Jia, Chao Luo, Huan Chen   +4 more
doaj   +1 more source

Dienogest and the breast

Gynecological Endocrinology, 2009
In a clinical pilot study, 21 women with endometriosis have been primarely treated with dienogest 2 x 10 mg daily p.o. for 24 weeks. Besides the effect on endometriosis the action of such high-dose progestogen treatment on the breast was evaluated by breast ultrasound prior to medication and at 24 weeks of medical treatment. In all women, a significant
Adolf E, Schindler, Alexandria, Henkel, Bernd, Christensen, Michel, Oettel, Claudia, Moore   +4 more
openaire   +2 more sources

Continuous Dienogest vs Cyclical Dienogest with Ethinyl Estradiol in the Management of Pelvic Endometriosis-A Prospective Interventional Study [PDF]

Journal of Clinical and Diagnostic Research, 2023
Introduction: Endometriosis is a disease of adolescents and women of reproductive age group characterised by the presence of endometrial tissue outside the uterine cavity.
Pattianchi T Sangma, Palash Mazumder, Dipa Mullick, Shyamali Dutta, Sukumar Mitra, Sohini Sen   +5 more
doaj   +1 more source